---
$id: https://graph.org.ai/products/commodity/51141575
$type: Product
source: UNSPSC
code: "51141575"
title: "Ralitoline"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ralitoline

**UNSPSC Code**: 51141575
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C13H13ClN2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q4MW9RM93A, chemically known as (z)-6-chloro-3-methyl-4-oxo-delta(sup 2,alpha)-thiazolidineaceto-o-toludide but generally known as ralitoline, which bears US NIH Compound Identifier 6436118. European Medicines Agency schedules Ralitoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10242MIG. The term RALITOLINE is an International Non-Proprietary Name. RALITOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ralitoline under HS 29341000 and SITC 51579. As of Q4 2014, RALITOLINE remains the US FDA Preferred Term for this commodity. Ralitoline bears US NLM identifiers UMLS ID C0072968 and NCI Concept Code C75165. SMILES: CLC1C(NC(=O)/C=C2\SCC(=O)N2C)C(CCC1)C.

